Tectonic Therapeutic, Ownership
| TECX Stock | 50.56 3.00 6.31% |
Shares in Circulation | First Issued 2017-06-30 | Previous Quarter 2.9 M | Current Value 14.7 M | Avarage Shares Outstanding 23.7 M | Quarterly Volatility 16.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Tectonic |
Tectonic Stock Ownership Analysis
About 39.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tectonic Therapeutic, recorded a loss per share of 3.07. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 21st of June 2024. To find out more about Tectonic Therapeutic, learn more at https://tectonictx.com.Besides selling stocks to institutional investors, Tectonic Therapeutic, also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Tectonic Therapeutic,'s stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Tectonic Therapeutic,'s strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Tectonic Therapeutic, Quarterly Liabilities And Stockholders Equity |
|
About 39.0% of Tectonic Therapeutic, are currently held by insiders. Unlike Tectonic Therapeutic,'s institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Tectonic Therapeutic,'s private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Tectonic Therapeutic,'s insider trades
Tectonic Therapeutic, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tectonic Therapeutic, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tectonic Therapeutic,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tectonic Therapeutic, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Marc Schwabish over two weeks ago Acquisition by Marc Schwabish of 2000 shares of Tectonic Therapeutic, at 2.38 subject to Rule 16b-3 | ||
Reicin Alise over two weeks ago Acquisition by Reicin Alise of 6000 shares of Tectonic Therapeutic, at 51.28 subject to Rule 16b-3 | ||
Ruddy Marcella K. over three weeks ago Acquisition by Ruddy Marcella K. of 18704 shares of Tectonic Therapeutic, at 5.38 subject to Rule 16b-3 | ||
Springer Timothy A over three months ago Acquisition by Springer Timothy A of 186134 shares of Tectonic Therapeutic, subject to Rule 16b-3 | ||
Reicin Alise over three months ago Acquisition by Reicin Alise of 33923 shares of Tectonic Therapeutic, at 2.38 subject to Rule 16b-3 | ||
Ruddy Marcella K. over six months ago Acquisition by Ruddy Marcella K. of 18704 shares of TECX at 5.38 subject to Rule 16b-3 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.